← Open Payments lookup

DANIEL BUTLER: Open Payments

NPI 1013320738 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$239,707 in 150 payments from 14 companies in 2025. Trend: 2023 $34,642 · 2024 $70,499 · 2025 $239,707

Speaker / faculty: $167,245Consulting: $54,914Travel & lodging: $13,425Food & beverage: $4,034Education: $90
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.45$65,280
GENZYME CORPORATION27$63,200
Galderma Laboratories, L.P.25$48,965
LEO Pharma Inc.24$40,706
Novartis Pharmaceuticals Corporation7$7,532
ABBVIE INC.11$5,938
Boehringer Ingelheim Pharmaceuticals, Inc.1$3,100
SANOFI US SERVICES INC.1$2,870
Arcutis Biotherapeutics, Inc.4$1,887
Janssen Biotech, Inc.1$80

Products named: DUPIXENT, NEMLUVIO, ADBRY, RINVOQ, SPEVIGO, AYVAKIT, ANZUPGO, Zoryve.

Industry payments across CA — which companies pay providers there.